[Fungal Infections]

Hanako Kurai1

  • 1Division of Infectious Diseases, Shizuoka Cancer Center Hospital.

Insights

Fungal infections in cancer patients can delay treatment and worsen survival. Understanding risk factors and early diagnosis, especially with immune checkpoint inhibitors (ICIs), is crucial for better outcomes.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Background:

  • Fungal infections are rare but serious complications in cancer patients, potentially delaying critical treatments like chemotherapy or surgery.
  • Common fungal pathogens include Candida, Aspergillus, Cryptococcus, and Pneumocystis jirovecii, necessitating a thorough understanding of their risk factors and clinical presentations.
  • The advent of immune checkpoint inhibitors (ICIs) like anti-PD-1, anti-PD-L1, and anti-CTLA-4 has revolutionized cancer treatment but can lead to immune-related adverse effects requiring immunosuppressive therapy, potentially increasing fungal disease risk.

Purpose of the Study:

  • To highlight the significance of fungal diseases as a complication in cancer patients.
  • To emphasize the importance of early diagnosis and understanding risk factors for fungal infections in oncology.
  • To discuss the potential increased risk of fungal infections associated with the use of immune checkpoint inhibitors and subsequent immunosuppressive therapies.

Main Methods:

  • Review of existing literature on fungal infections in cancer patients.
  • Analysis of common fungal pathogens and their prevalence.
  • Examination of the impact of cancer treatments, including chemotherapy, surgery, and immune checkpoint inhibitors, on fungal disease risk.

Main Results:

  • Fungal infections can lead to significant delays in cancer treatment, negatively impacting patient survival.
  • Candida, Aspergillus, Cryptococcus, and Pneumocystis jirovecii are the primary fungal agents causing infections in this population.
  • Immune checkpoint inhibitors (ICIs) and associated immunosuppressive therapies may elevate the risk of developing fungal diseases.

Conclusions:

  • Early detection and management of fungal infections are vital for improving overall survival in cancer patients.
  • Awareness of the specific risks associated with different fungal pathogens and cancer therapies is essential for clinical practice.
  • Further research is needed to elucidate the complex interplay between ICIs, immunosuppression, and fungal infections in cancer care.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
321
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
868
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
843
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
1.4K
Fungal Phylum Basidiomycota01:26

Fungal Phylum Basidiomycota

Basidiomycota is a diverse phylum of fungi that includes ecologically significant decomposers such as white rot fungi, symbionts like mycorrhizal fungi, plant pathogens such as rusts and smuts, and edible species like Agaricus bisporus (the common button mushroom). These fungi play crucial roles in nutrient cycling, symbiotic relationships, and even human health. Their defining feature is the basidium, a microscopic club-shaped structure responsible for producing basidiospores.Fruiting Bodies...
717